Insiders · Profile

Porter Derrell

Director at Acumen Pharmaceuticals · SVP, Head of Global Commercial at Atara Biotherapeutics. Filing since 8 May 2018. CIK 0001706400

Company
Date
Role
Action
Shares
Amount
Of holding
17 Jun 2026
Director
Sold at will
13,040
$30.32K
26.9%
16 Jun 2026
Director
Sold at will
12,800
$29.77K
26.5%
15 Jun 2026
Director
Sold at will
6,460
$15.15K
11.8%
15 Feb 2019
SVP, Head of Global Commercial
Sold, plan not stated
5,909
$236.36K
21.4%
15 May 2018
SVP, Head of Global Commercial
Sold, plan not stated
16,334
$735.36K
56.6%
8 May 2018
SVP, Head of Global Commercial
Sold, plan not stated
1,544
$61.99K
11.0%
6 decisions on file.